By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Enhance Biotech Inc. 

1 Rockefeller Plaza, Suite 1600

New York  New York  10020  U.S.A.
Phone: 212-561-1716 Fax: 212-265-4680




Company News
Enhance Biotech Inc. Announces Asset Sale Agreement With Mount Cook Biosciences For Delta Receptor Portfolio 5/22/2006 11:17:58 AM
Enhance Biotech Inc. Announces Closing Of Merger With Ardent Pharmaceuticals10/19/2005 5:12:31 PM
Enhance Biotech Inc.'s New Merger Partner Ardent Pharmaceuticals Announces License Agreement With ALZA Corporation (JNJ) For Pain Compound 10/19/2005 5:12:03 PM
Enhance Biotech Inc. Announces Recruitment Of Patients For Dose Ranging Study Prior To Commencement Of Phase III Trial For Premature Ejaculation Compound LI30110/19/2005 5:11:44 PM
Enhance Biotech Inc. Achieves Milestones To Complete $4 Million Funding Arrangement10/19/2005 5:11:27 PM
Enhance Biotech Inc. Announces Further Progress With LI 316 Fertility Enhancement Products As They Move Towards Trials In Animal Fertility10/19/2005 5:11:22 PM
Enhance Biotech Inc. Discovers Unique Mechanism Of Action For Cellulite Treatment In Preparation For Regulatory Submission10/19/2005 5:11:21 PM
Enhance Biotech Inc. Appoints Internationally Acclaimed Pre-clinical Expert And Entrepreneur David Scales LLM, Ph.D., FIBiol, FRCPath To Its Board Of Directors10/19/2005 5:11:14 PM
Enhance Biotech Inc. To Merge With Privately-Held Ardent Pharmaceuticals10/19/2005 5:11:00 PM
Enhance Biotech Inc. Announces Consulting Agreement With SoleRx LLC To Accelerate Development Of Dermatology Drugs10/19/2005 5:10:56 PM